AMD Archives - CDR – Chain Drug Review

Bausch + Lomb intros PreserVision AREDS 2 chewable vitamins

May 1, 2018 by Chain Drug Review AMD, Bausch + Lomb, Joseph Gordon, PreserVision AREDS 2 Formula + Multivitamin, PreserVision AREDS 2 Formula Chewable vitamins Supplier News

BRIDGEWATER, N.J. – Bausch + Lomb announced the introduction of PreserVision AREDS 2 Formula Chewable vitamins, which were designed to meet the growing consumer preference for chewable tablets, in a mixed berry flavor. PreserVision AREDS 2 Formula vitamins are the only vitamins that contain the exact levels of six key nutrients recommended by the National

Bausch + Lomb campaign helps raise awareness of AMD

February 6, 2018 by Bill Schiffner #WhyEyeFight, Age-related Macular Degeneration, AMD, Bausch + Lomb, Bausch + Lomb Consumer Healthcare, Jeff Todd, Joe Gordon, Lester Hosten, Michael Cooney, Prevent Blindness Supplier News

NEW YORK – Bausch + Lomb has launched a new public service announcement and docu-series to raise awareness of age-related macular degeneration (AMD), a leading cause of vision loss in people ages 50 and older. Unveiled at a media event Tuesday in New York City, the Bausch + Lomb docu-series shares the stories of people